F. Gilbert Bickel
Director/Miembro de la Junta en St. Louis Regional Chamber & Growth Association .
Perfil
F.
Gilbert Bickel is currently a Director at St. Louis Regional Chamber & Growth Association.
Prior to this, he was a Director at Sequoia Vaccines, Inc.
Cargos activos de F. Gilbert Bickel
| Empresas | Cargo | Inicio |
|---|---|---|
St. Louis Regional Chamber & Growth Association
 St. Louis Regional Chamber & Growth Association Miscellaneous Commercial ServicesCommercial Services St. Louis Regional Chamber & Growth Association operates as a non-profit organization, which engages in economic development business and public policy. The company was founded in 1836 and is headquartered in St. Louis, MO. | Director/Miembro de la Junta | - |
Antiguos cargos conocidos de F. Gilbert Bickel.
| Empresas | Cargo | Fin |
|---|---|---|
Sequoia Vaccines, Inc.
 Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | Director/Miembro de la Junta | - |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
St. Louis Regional Chamber & Growth Association
St. Louis Regional Chamber & Growth Association Miscellaneous Commercial ServicesCommercial Services St. Louis Regional Chamber & Growth Association operates as a non-profit organization, which engages in economic development business and public policy. The company was founded in 1836 and is headquartered in St. Louis, MO. | Commercial Services |
Sequoia Vaccines, Inc.
Sequoia Vaccines, Inc. BiotechnologyHealth Technology Sequoia Vaccines, Inc. is a clinical stage pharmaceutical company engages in developing vaccine to prevent recurrent urinary tract infections and small molecules treating cancers and bacterial infections. The company was founded by Gary Eldridge in 2012 and is headquartered in St. Louis, MO. | Health Technology |
- Bolsa de valores
- Insiders
- F. Gilbert Bickel
